Browsing Tag
AmBisome
3 posts
F2G and Shionogi move closer to commercializing novel oral antifungal after pivotal trial results
Shionogi shares gain as olorofim's Phase 3 success advances its F2G partnership. Explore the $480M deal, FDA plans and market potential.
Aurobindo Pharma announces FDA final approval for Amphotericin B Liposome for Injection
Aurobindo Pharma said that its fully-owned subsidiary — Eugia Pharma Specialities has secured final approval for Amphotericin B…
Cadila Healthcare to bring Black Fungus drug AmphoTLC to India
Cadila Healthcare (also known as Zydus Cadila) has signed a license supply and commercialization agreement with Taiwanese pharma…